Skip to content

Clinical trials

Phase 1/2 Neoplasms by Site trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Phase: Phase 1/2 Country / region: Belgium Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20172
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BBB-Therapeutics B.V.1
Eli Lilly and Company1
Hoffmann-La Roche1
Stemline Therapeutics, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms5
Neoplasms by Site5
Breast Neoplasms3
Head and Neck Neoplasms3
Lung Neoplasms3
Adenocarcinoma2
Brain Diseases2
Brain Neoplasms2
Breast Diseases2
Bronchial Neoplasms2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.